Chapter 11 — Case Study 2: Carbocations in Biology — From Glycosidic Bonds to Steroid Biosynthesis
How "free" carbocations, traditionally seen as laboratory species, turn out to be central intermediates in the biosynthesis of sugars, steroids, and other essential molecules.
1. The biological skepticism — and its overthrow
For most of the 20th century, biochemists thought biology avoided carbocations. The reasoning was straightforward: - Carbocations are highly electrophilic and reactive. - The cell is full of nucleophiles (water, amines, alcohols, lots of nucleophilic atoms). - A free carbocation in such an environment should be captured almost immediately, indiscriminately, and irreversibly.
Therefore, the thinking went, biology must avoid free cations and use other mechanisms (ionic stepwise without true cation, or radical, or concerted) for what looked like cation-mediated chemistry.
This view was wrong. Modern enzymology has shown that enzyme-bound carbocations are common, controlled, and essential in many biosynthetic pathways. The active site provides the constraint that the test tube does not — holding the cation in geometry, surrounding it with specific stabilizing atoms, and steering the cation toward a specific product.
The chemistry is still $S_N1$-like. But the enzyme controls the intermediate's fate.
2. Glycosidic bond formation: the oxocarbenium intermediate
Glycosidic bonds connect sugars to each other (in di- and polysaccharides like starch, cellulose, glycogen) and to other molecules (in glycoproteins and glycolipids). The bond is between the C1 of one sugar (the "anomeric carbon") and an oxygen, nitrogen, or sulfur of another molecule.
Formation of a glycosidic bond proceeds via a stabilized cation intermediate called an oxocarbenium ion:
R-O-CH-OR' (acetal) → R-O-CH+ (cation) + R'-OH
|
OR'
In the cation, the positive charge is shared between C and the adjacent O:
R-O-CH+ ↔ R-O+=CH
The structure is more stable than a typical alkyl cation.
The oxocarbenium has resonance structures: - One with the positive charge on C and a single bond to O. - One with C=O double bond and the positive charge on O.
This delocalization makes the oxocarbenium ~25-30 kcal/mol more stable than a typical primary or secondary cation. That extra stability allows it to form on a measurable timescale at body temperature.
Glycosyl transferases
Enzymes that catalyze glycosidic bond formation are called glycosyl transferases. They transfer a sugar from a "donor" (often a nucleotide-sugar like UDP-glucose or GDP-mannose) to an "acceptor" (often the OH of another sugar or a serine/threonine of a protein).
The mechanism for many of these enzymes: 1. Bind the donor (e.g., UDP-glucose). 2. Activate via cation formation: the C1 of the sugar partially ionizes, releasing UDP and forming an oxocarbenium intermediate. 3. The acceptor's nucleophile (an OH on another sugar) attacks the oxocarbenium from one face. 4. New glycosidic bond is formed; the enzyme releases the product.
The active site stabilizes the oxocarbenium through specific electrostatic interactions — typically a carboxylate (Asp or Glu) positioned to stabilize the developing positive charge. Without the carboxylate, the cation would be too unstable to form; with it, the reaction proceeds at biological rate.
The stereochemistry depends on the enzyme: some give "inverting" products (one face attack only), others give "retaining" products (a double-displacement mechanism with two attacks from the same face). Both are mechanistically $S_N1$-like at the C1 position.
3. Steroid biosynthesis: the squalene cyclization
The most spectacular example of biological cation chemistry is the cyclization of squalene to lanosterol — a single enzyme reaction that creates four new rings, eight new stereocenters, and the entire steroid skeleton in one step.
The substrate, squalene (a $C_{30}$ linear hydrocarbon with six C=C bonds), is folded in the active site of the enzyme squalene cyclase. An aspartate residue protonates one of the alkene bonds, generating a tertiary cation. From there:
- The cation attacks the next alkene π bond, forming a new C-C bond and a new cation at the next position.
- That cation attacks the next alkene, and so on.
- Six successive cation-alkene cyclizations form four fused rings.
- A series of 1,2-hydride and 1,2-methyl shifts (rearrangements!) reorganize the carbon skeleton.
- A final proton loss completes the molecule.
The whole cascade — six new C-C bonds, eight new stereocenters, a complete reorganization of the carbon skeleton — happens in one enzyme active site, in one continuous concerted-with-rearrangements mechanism. The intermediate cations are held in proper geometry so that each step proceeds with the right stereochemistry.
The chemistry is exactly Chapter 11 chemistry, applied at scale, controlled by an enzyme. Without the enzyme, squalene would react with random nucleophiles or rearrange unproductively. With the enzyme, it makes lanosterol, the precursor to cholesterol.
This is one of the most beautiful examples of organic chemistry in biology. It is also one of the most carbocation-dependent.
4. Other biological cation chemistry
Beyond glycosides and steroids, cation chemistry shows up throughout biology:
Terpene biosynthesis: many natural products (limonene, menthol, camphor, terpinolene) are made by cation-mediated cyclizations of geranyl- or farnesyl-pyrophosphate. The pyrophosphate is the leaving group; the resulting cation cyclizes through a series of alkene attacks and rearrangements.
Cholesterol → bile acids: hydroxylations of cholesterol and side-chain modifications proceed via cation intermediates in some cases (hydroxylase enzymes use radical chemistry; but the side-chain shortening involves cations).
Polyketide biosynthesis (lovastatin, erythromycin, many antibiotics): involves Claisen-like additions but also some cation rearrangements.
Carotenoid biosynthesis (β-carotene, lycopene): isoprenoid cyclizations via cation intermediates.
Penicillin biosynthesis: the β-lactam ring is formed via complex chemistry involving radicals, but some neighboring acyl-CoA intermediates are cation-stabilized.
In each case, the enzyme provides the constraint that the test tube does not. The chemistry is the same — cation formation, attack by adjacent nucleophile, possible rearrangement — but the enzyme's active site directs the reaction to a specific product.
5. The lesson for Chapter 11
For a long time, $S_N1$ was thought to be a "lab" mechanism — a thing chemists do in test tubes that biology avoids. The discovery (over the second half of the 20th century) that cations are widely used in biology, and even controlled with extraordinary precision, has reframed our understanding.
What changes between the lab $S_N1$ and the biological one is:
| Feature | Lab $S_N1$ | Biological cation |
|---|---|---|
| Cation lifetime | nanoseconds to microseconds | controlled by enzyme; can be much shorter |
| Stabilization | solvent only | solvent + active-site residues |
| Selectivity | nucleophile diffuses in randomly | enzyme places nucleophile precisely |
| Rearrangement | unpredictable | controlled by enzyme geometry |
| Yield | often mixed products | typically very clean |
The chemistry is the same. The control is what differs.
When you draw an $S_N1$ mechanism in your homework — t-butyl bromide solvolyzing in water, the cation living briefly before being captured — you are drawing the same chemistry that runs in your liver right now, where glycosyl transferases are forming glycosidic bonds via oxocarbenium intermediates and squalene cyclase is making lanosterol.
The carbocation is real. It has biological consequences. Chapter 11's mechanism is the chemistry behind some of the most extraordinary reactions in biology.
Further reading: - Lairson, L. L., Henrissat, B., Davies, G. J., and Withers, S. G. (2008). Glycosyltransferases: structures, functions, and mechanisms. Annu. Rev. Biochem. 77, 521. - Wendt, K. U., and Schulz, G. E. (1998). Isoprenoid biosynthesis: manifold chemistry catalyzed by similar enzymes. Structure 6, 127. - Christianson, D. W. (2017). Structural and chemical biology of terpenoid cyclases. Chem. Rev. 117, 11570. - Wendt, K. U., Schulz, G. E., et al. (1997). The structure of squalene cyclase. Science 277, 1811. (The first crystal structure of an enzyme that catalyzes squalene cyclization, providing direct evidence for the cation-cascade mechanism.)